| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (38件)
- Yuya Tomioka, Naohiko Seki, Takayuki Suetsugu, Yoko Hagihara, Hiroki Sanada, Yusuke Goto, Naoko Kikkawa, Keiko Mizuno, Kentaro Tanaka, Hiromasa Inoue. Identification of Tumor Suppressive miR-144-5p Targets: FAM111B Expression Accelerates the Malignant Phenotypes of Lung Adenocarcinoma. International journal of molecular sciences. 2024. 25. 18
- Yusuke Sunanaga, Takayuki Suetsugu, Yusuke Nagata, Marina Miyata, Kiyotaka Kondo, Hideo Mitsuyama, Shingo Kubota, Keiko Mizuno, Kentaro Tanaka, Hiromasa Inoue. Cytomegalovirus cavitary pneumonia in a human immunodeficiency virus-infected patient. Respirology case reports. 2024. 12. 5. e01392
- Takahiro Matsuyama, Masashi Oniwa, Kentaro Tsuruzono, Shunsuke Yasuda, Mikiko Yone, Yuya Tomioka, Akifumi Uchida, Hideo Mitsuyama, Shingo Kubota, Takayuki Suetsugu, et al. Improving visual acuity with nivolumab plus ipilimumab plus two cycles of chemotherapy following a diagnosis of lung adenocarcinoma with choroidal metastasis: A case report and literature review. Respirology case reports. 2024. 12. 1. e01262
- Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu, Masahiro Shinmura, Shunsuke Misono, Yusuke Goto, Naoko Kikkawa, Mayuko Kato, Hiromasa Inoue, Keiko Mizuno, et al. Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers. 2023. 15. 23
- 垣内 洋祐, 猿渡 功一, 時任 高章, 入來 豊久, 岩川 純, 坂田 能彦, 神宮 直樹, 佐伯 祥, 稲葉 恵, 高木 僚, et al. 75歳以上の局所進行非小細胞肺癌に対する化学放射線治療後のデュルバルマブ維持療法の有効性と安全性の検討. 肺癌. 2023. 63. 5. 457-457
- Kengo Tanigawa, Yuya Tomioka, Shunsuke Misono, Shunichi Asai, Naoko Kikkawa, Yoko Hagihara, Takayuki Suetsugu, Hiromasa Inoue, Keiko Mizuno, Naohiko Seki. Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. FEBS open bio. 2023
- Yuya Tomioka, Takayuki Suetsugu, Naohiko Seki, Kengo Tanigawa, Yoko Hagihara, Masahiro Shinmura, Shunichi Asai, Naoko Kikkawa, Hiromasa Inoue, Keiko Mizuno. The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma. Cells. 2023. 12. 14
- Keisuke Tabata, Masaya Aoki, Ryo Miyata, Tadashi Umehara, Aya Harada-Takeda, Go Kamimura, Toshiyuki Nagata, Ryuya Okizono, Hideyuki Terazono, Yasuo Takeda, et al. Successful Treatment with Osimertinib Based on Therapeutic Drug Monitoring in a Hemodialysis Patient with Non-Small Cell Lung Cancer: A Case Report. Case reports in oncology. 2023. 16. 1. 705-710
- Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Katsuhiko Shimizu, Takeshi Masuda, Katsumi Nakatomi, Shigeo Kawase, et al. Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers. Advances in clinical chemistry. 2023. 112. 155-204
- Kengo Tanigawa, Shunsuke Misono, Keiko Mizuno, Shunichi Asai, Takayuki Suetsugu, Akifumi Uchida, Minami Kawano, Hiromasa Inoue, Naohiko Seki. MicroRNA signature of small cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control. Molecular oncology. 2022
- 米 未紀子, 安田 俊介, 里村 緑, 谷川 健悟, 美園 俊祐, 内田 章文, 三山 英夫, 末次 隆行, 水野 圭子, 井上 博雅. 当院で経験した胸腺癌症例の検討. 日本呼吸器学会誌. 2022. 11. 増刊. 279-279
- 大庭 優士, 安田 俊介, 鶴薗 健太郎, 冨岡 勇也, 松山 崇弘, 三山 英夫, 末次 隆行, 水野 圭子, 井上 博雅, 田畑 和宏, et al. イピリムマブ+ニボルマブ+カルボプラチン+ペメトレキセド併用療法で視力の改善が得られた脈絡膜転移を有する肺腺癌の1例. 肺癌. 2022. 62. 2. 141-141
- Keiko Mizuno, Kengo Tanigawa, Shunsuke Misono, Takayuki Suetsugu, Hiroki Sanada, Akifumi Uchida, Minami Kawano, Kentaro Machida, Shunichi Asai, Shogo Moriya, et al. Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma. Biomedicines. 2021. 9. 12
- Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, Hirotsugu Kenmotsu, Hiroshi Mukae, Kentaro Ito, Kenji Chibana, Kohji Inoue, Satoru Miura, Kentaro Tanaka, et al. A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2021. 16. 12. 2121-2132
- Takayuki Takahashi, Hideyuki Terazono, Takayuki Suetsugu, Hideki Sugawara, Junko Arima, Mina Nitta, Toru Tanabe, Kayu Okutsu, Ryuji Ikeda, Keiko Mizuno, et al. High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction. Cancers. 2021. 13. 14
- Atsushi Osoegawa, Masafumi Yamaguchi, Tomomi Nakamura, Ryotaro Morinaga, Kentaro Tanaka, Kosuke Kashiwabara, Takashi Miura, Takayuki Suetsugu, Taishi Harada, Tatsuma Asoh, et al. High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib. JTO clinical and research reports. 2021. 2. 7. 100191-100191
- Naoko Sueoka-Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda, et al. The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment. Cancer medicine. 2021. 10. 12. 3873-3885
- 藤崎 志郎, 上川路 和人, 三山 英夫, 末次 隆行, 水野 圭子, 井上 博雅. 当科における大細胞神経内分泌癌の臨床的検討. 日本呼吸器学会誌. 2021. 10. 増刊. 295-295
- Shunsuke Misono, Keiko Mizuno, Takayuki Suetsugu, Kengo Tanigawa, Nijiro Nohata, Akifumi Uchida, Hiroki Sanada, Reona Okada, Shogo Moriya, Hiromasa Inoue, et al. Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target. Cancers. 2021. 13. 6
- Keiko Mizuno, Kengo Tanigawa, Nijiro Nohata, Shunsuke Misono, Reona Okada, Shunichi Asai, Shogo Moriya, Takayuki Suetsugu, Hiromasa Inoue, Naohiko Seki. FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p). Cells. 2020. 9. 9
前のページに戻る
